Inventor · disambiguated record
Rajashree Joshi-Hangal
Also filed as: JOSHI-HANGAL RAJASHREE
16 granted patents·9 pending applications·212 citations·filing 2001–2021
94Inventor score
Top patents by PatentIndex Score
25 records- 0193US6538020B2Paclitaxel formulationSUPER GEN INC·Filed 2001·Granted Mar 25, 2003·41 cites·20 claims
- 0293US6509370B1Paclitaxel formulationSUPERGEN INC·Filed 2002·Granted Jan 21, 2003·36 cites·26 claims
- 0389US7135464B2Method of administering decitabineSUPERGEN INC·Filed 2004·Granted Nov 14, 2006·33 cites·11 claims
- 0488US6828346B2Methods for administration of paclitaxelSUPERGEN INC·Filed 2003·Granted Dec 7, 2004·26 cites·48 claims
- 0587US10519190B2Drug compound and purification methods thereofOTSUKA PHARMA CO LTD·Filed 2018·Granted Dec 31, 2019·3 cites·24 claims
- 0687US9913856B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·6 cites·14 claims
- 0786US6710195B2Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2002·Granted Mar 23, 2004·21 cites·70 claims
- 0885US10485764B2Lyophilized pharmaceutical compositionsOTSUKA PHARMA CO LTD·Filed 2016·Granted Nov 26, 2019·4 cites·36 claims
- 0985US6982253B2Liquid formulation of decitabine and use of the sameSUPERGEN INC·Filed 2002·Granted Jan 3, 2006·21 cites·79 claims
- 1083US9381207B2Drug formulationsJOSHI-HANGAL RAJASHREE·Filed 2012·Granted Jul 5, 2016·9 cites·40 claims
- 1180US10517886B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·2 cites·12 claims
- 1278US10858386B2Drug compound and purification methods thereofOTSUKA PHARMA CO LTD·Filed 2019·Granted Dec 8, 2020·1 cites·27 claims
- 1378US7144873B2Kit for delivering decitabine in vivoSUPERGEN INC·Filed 2004·Granted Dec 5, 2006·9 cites·14 claims
- 1475US11058705B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·0 cites·19 claims
- 1568US2022016033A1Lyophilized pharmaceutical compositionsOTSUKA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1666US7820684B2Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using sameSUPERGEN INC·Filed 2008·Granted Oct 26, 2010·0 cites·13 claims
- 1766US2020093748A1Lyophilized pharmaceutical compositionsOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1864US2022024965A1Drug compound and purification methods thereofOTSUKA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1958US8445502B2Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using sameBEARSS DAVID J·Filed 2010·Granted May 21, 2013·0 cites·8 claims
- 2052US2004167205A1Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2004·Application pending·0 cites
- 2147US2006014949A1Compositions and formulations of decitabine polymorphs and methods of use thereofSUPERGEN INC·Filed 2004·Application pending·0 cites
- 2243US2006128654A1Pharmaceutical formulation of cytidine analogs and derivativesTANG CHUNLIN·Filed 2004·Application pending·0 cites
- 2343US2006128653A1Pharmaceutical formulation of decitabineTANG CHUNLIN·Filed 2004·Application pending·0 cites
- 2439US2017360791A1Pharmaceutical compositions for increasing the bioavailability of poorly soluble drugsASTEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2539US2018169117A1Pharmaceutical formulation comprising a substituted phenyl - (1,3-dihydro-isoindol-2-yl) - methanoneOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rajashree Joshi-Hangal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →